Entry into a Material Definitive Agreement. On August 14, 2026, MicroVision, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with the purchasers listed on the signature pages thereto (the “Purchasers”), in connection with the Company’s offer of an aggregate of 6,800,000 shares (the “Shares”) of its common stock, par value $0.001 per share (the “Common Stock”), together with accompanying warrants to purchase 6,800,000 shares of Common Stock (the “Wa…

CFO — Christine Chambers: The filing primarily announces the external hire of a new CFO to replace an interim officer, which is a standard executive appointment rather than a sudden departure or loss of leadership.

Results of Operations and Financial Condition. The information in this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended. On August 6, 2026, MicroVision, Inc. iss…

Material Modification to Rights of Security Holders. On July 10, 2026 at the Company’s annual meeting of shareholders (the “Annual Meeting”), the shareholders of MicroVision, Inc. (the “Company”) approved an amendment (the “Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) to (i) effect a reverse stock split (the “Reverse Stock Split”) of the Company’s common stock, par value $.001 per share (“Common Stock”), at…

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On June 12, 2026, the Company submitted an application to transfer the listing of the Company’s Common Stock from The Nasdaq Global Market to The Nasdaq Capital Market. The Company’s transfer application is subject to review and approval by the staff of the Nasdaq Stock Market (“Nasdaq”). As previously disclosed in the Company’s Current Report on Form 8-K filed on January 16, 2026, the Company…

Entry into a Material Definitive Agreement. On June 12, 2026, MicroVision, Inc. (the “Company”) and the Agents (as defined herein) entered into Amendment No. 1 (“Amendment No. 1”) to that certain At-The-Market Issuance Sales Agreement, dated March 5, 2024 (the “Sales Agreement”), by and among the Company and Deutsche Bank Securities Inc., Mizuho Securities USA LLC and Craig-Hallum Capital Group LLC (collectively, the “Agents”), pursuant to which the Company may offer and sell, from time to ti…

Regulation FD. The information in this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended. On June 10, 2026, the Company issued a press release announcing the sign…

Results of Operations and Financial Condition. The information in this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended. On May 13, 2026, MicroVision, Inc. issue…

Results of Operations and Financial Condition. The information in this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended. On March 4, 2026, MicroVision, Inc. issu…

Termination of a Material Definitive Agreement. The information disclosed in

Unregistered Sales of Equity Securities. The information disclosed in

Entry into a Material Definitive Agreement. On February 23, 2026, MicroVision, Inc. (the “Company”) entered into a Securities Purchase and Exchange Agreement (the “Purchase Agreement”) for the exchange of senior secured convertible notes due 2026 for senior secured convertible notes due 2028 (the “Exchanged Note”) and the purchase of senior secured convertible notes due 2028 (the “New Note” and together with the Exchanged Note, the “Convertible Notes”) with an institutional investor (the “Hol…

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet. The information disclosed in

Completion of Acquisition of Assets. As previously disclosed in our Current Report on Form 8-K filed on January 30, 2026 with the U.S. Securities and Exchange Commission (the “SEC”), MicroVision, Inc. (“MicroVision” or the “Company”) entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”) with Luminar Technologies, Inc. (“Luminar”), pursuant to which MicroVision agreed to acquire from Luminar certain assets related to Luminar’s lidar sensor business (the “Acquisition”). On F…

Entry into a Material Definitive Agreement. On January 26, 2026 (the “Signing Date”), MicroVision, Inc. (“MicroVision” or the “Company”) entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”) with Luminar Technologies, Inc. (“Luminar”), pursuant to which MicroVision has agreed to acquire from Luminar certain assets related to Luminar’s lidar sensor business, including intellectual property and inventory related to its Iris and Halo sensors. The acquisition does not include…

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 12, 2026, MicroVision, Inc. (the “Company”) received a notification letter from The Nasdaq Stock Market (“Nasdaq”) advising that, based upon the closing bid price for the last 30 consecutive business days, the Company no longer meets the continued listing requirement to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listing Rule 5450(a)(1). The notification fro…

Chief Financial Officer — Anubhav Verma: Mr. Verma resigned from his position as CFO.

Results of Operations and Financial Condition. The information in this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended. On November 11, 2025, MicroVision, Inc.…

CEO — Sumit Sharma: Glen W. DeVos was promoted to President and CEO, replacing Sumit Sharma who will receive severance benefits.

Results of Operations and Financial Condition. The information in this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended. On August 7, 2025, MicroVision, Inc. iss…

Director — Dr. Mark Spitzer: Dr. Mark Spitzer retired and was succeeded by Laura Peterson as a Director.

The filing details compensation and equity arrangements for executives, not a management change.

Changes in Registrant’s Certifying Accountant On June 3, 2025, MicroVision, Inc. (the “Company”) was notified that Moss Adams LLP (“Moss Adams”), the Company’s independent registered public accounting firm, merged with Baker Tilly US, LLP effective on June 3, 2025. The combined audit practices operate as Baker Tilly US, LLP (“Baker Tilly”). In connection with the notification of the merger, Moss Adams has resigned as the auditors of the Company and the Audit Committee of the Company’s Board o…

Results of Operations and Financial Condition. The information in this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended. On May 12, 2025, MicroVision, Inc. issue…

Results of Operations and Financial Condition. The information in this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended. On March 26, 2025, MicroVision, Inc. iss…